FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS. EJHSMI [Internet]. 2026 Jun. 8 [cited 2026 Jun. 16];2(6):1-11. Available from: https://eurekaoa.com/index.php/5/article/view/1148